Find an expert

Helen works across a range of projects in both the research and consultancy arms of the Centre for Online Health, Centre for Health Services Research. Her focus is on the effective use of technology to increase access to health interventions (e.g. online psychoeducational tools for carers; telehealth implementation, telemental health and allied health) and increasing health literacy in the community (e.g. dementia knowledge and digital health). She is particularly interested in using health technology to promote quality end-of-life care. Her current projects aim to increase care closer to home for people with dementia and with life-limiting illnesses (e.g. telepalliative care). In 2023, she was awarded a 3-year National Palliative Care Project Grant funding to lead a national palliative care telementoring project - Palliative Care ECHO. Other research includes: evaluation of telepalliative care services (e.g. patient/ carer outcomes and perceptions and staff perceptions); mental health interventions via telehealth and social media and; online psychoeducational support for carers of people with primary brain tumours in order to increase quality of life and mental wellbeing.

Helen coordinates a range of COH consultancy projects.

She is a Registered Psychologist with clinical experience working with a range of issues and diverse populations and has over ten years’ experience teaching and facilitating workshops on psychology and health communication.

Genevieve is a Professor of Physical Activity and Health at the University of Queensland and an MRFF Emerging Leadership Fellow. Her research focuses on sedentary behaviour and physical activity in adults across the 24-hour day, including understanding impacts on health, wellbeing and performance, and the feasibility, acceptability and sustainability of modifying these behaviours in key settings and populations including desk-based workers and those with or at risk of type 2 diabetes. Co-design with stakeholders and end-users is embedded across her research program, which includes working with government, clinical, public health, private industry, not-for-profit, community and workplace partners in research and its’ translation into policy and practice. She leads the BeUpstanding program of research - an online workplace health and wellbeing initiative supporting teams of desk-based workers to reduce their sedentary time

Dr Anthony Herbert has trained in paediatrics at both the Mater Children's and Royal Children's Hospitals in Brisbane. He also worked at the Alberta Children's Hospital in Calgary, Alberta, Canada for a year in 2001. He completed training in paediatric medical oncology. He subsequently completed a fellowship in paediatric palliative care working with both adults at the Mater Health Services and with children at The Children's Hospital at Westmead (CHW) in Sydney, Australia. At CHW, he was able to gain a broad exposure to all aspects of pain medicine and palliative care including experience in the use of patient controlled analgesia (PCA), multi-disciplinary management of persistent pain and hospice care (at Bear Cottage). During this time, he developed a particular interest in cancer pain management.

Anthony commenced work as a Staff Specialist in Paediatric Palliative Care with Children's Health Queensland Hospital and Health Service in September 2008. At this time he was based at the Royal Children's Hospital, Brisbane, but also consulted at the Mater Children's Hospital, Brisbane. In November 2014, the Lady Cilento Children's Hospital (LCCH) opened in Brisbane. Anthony became the Director of the Paediatric Palliative Care Service at LCCH in June 2015.

Research interests have included telehealth, insomnia, music therapy, perinatal palliative care, service development, respite provision and communication in paediatric palliative care. He has also had an interest in education related to palliative care - for undergraduates and post graduate students. More recently he has been involved in the Quality of Care Collaborative of Australia (QuoCCA) which is a national project (funded by the Department of Health, Commonwealth) looking at education provision, particularly in rural and remote settings. As part of this work, Anthony has also developed an interest in the education of undergraduate students in paediatric palliative care, particularly at the time of short clinical placements. In this context, he has found the resources of the Palliative Care Curriculum for Undergraduates (PCC4U) particularly helpful. His interest in providing education has also extended to Vietnam and Malaysia.

Dr Anthony Herbert was Chair of the Australian and New Zealand Paediatric Palliative Care National Reference Group from 2012 - 2013. He has also been chair of the Palliative Care Working Group of the Child and Youth Network in Queensland from 2012. Anthony has also been a committee member of the Chapter of Palliative Medicine linked to the Royal Australasian College of Physicians. He was involved in the recent writing of "Palliative Care" (Version 4) with Therapeutic Guidelines. He has also been an active contributor to the national resource "A Practical Guide to Palliative Care in Paediatrics".

Developmental and Behavioural Paediatrician with a dual qualification in Sleep Medicine

Honey trained initially at UQ and the Mater Chidlren's Hospital before spending time in Melbourne at the RWH and RCH ( Murdoch Institute)Her Doctorate in the Behavioural and Attentional consequences of Adenotonsillectomy was completed through the University of Nottingham where she was a Lecturer in Community Paediatrics.

She has a significant role in teaching and assessment in the Paediatrics and Child Health rotation and has a strong interest in medical education. Her clinical work involves children with a variety of Developmental and Behavioural problems as well as a number of clinics that specialise in Sleep disorders for this population. She also runs a specialised clinics for some genetic disorders.

She has a number of research interests that reflect her clinical practice.

Senior Research Fellow

Room 7048, Level 7, Pharmacy Australia Centre of Excellence Phone:+61 7 334-61898; Fax: +61 7 334-61999 Email: a.hewavitharana@pharmacy.uq.edu.au

Amitha obtained her B.Sc. from the University of Colombo (Sri Lanka), M.Sc. from the university of Victoria (B.C., Canada) and PhD in analytical chemistry from the University of Alberta (Canada). Following that, she held brief research positions at the Massey University (New Zealand) and NZ Leather Research Institute. She then held a research scientist position at the NZ Dairy Research Institute (NZDRI, currently Fonterra Research) for 4 years before moving to Australia in 1997.

In Australia, she commenced her career as a lecturer in analytical chemistry at the University of Western Sydney, and then at Queensland University of Technology (QUT) until 2001. Following that, she held research positions in CSIRO (food science) and in QHSS (investigative chemistry) before joining the school of pharmacy in 2004.

A/Prof Ingrid Hickman is a Principal Research Fellow in Implementation Science with the UQ ULTRA team (Clinical Trial Capability) located within the Centre for Clinical Research in Herston. A/Prof Ingrid Hickman is an implementation scientist and has over 20 years experience in health services clinical research. Her career has focused on research excellence, strategic leadership and translating scientific evidence into improved clinical care for people with complex chronic conditions. From randomised controlled trials and mechanisms of disease progression through to patient centred co-design of health services, her collaborative approach to research aims to find solutions to health care problems. Prior to taking up the role with the ULTRA team, A/Prof Hickman led the Metabolic Obesity Research Group and the Nutrition Research Program at the Princess Alexandra Hospital in Brisbane for over 12 years. Within this role she has been a passionate advocate for embedding implementation science and methodologies into clinical trials and health services research and has been recognised internationally for her investment in implementation science and clinical workforce capacity building in research translation.

Professor Leanne Hides is the Director of the NHMRC Centre of Research Excellence on Meaningful Outcomes in Substance Use Treatment and the Deputy Director of the National Centre for Youth Substance Use Research (NCYSUR)

Professor Hides is a clinical psychologist with over 25 years of experience working on the interface of alcohol and other drug (AOD) clinical research and practice. Her translational research program co-designs, trials and implements innovative AOD treatments into clinical practice. She has been a chief investigator on over 40 randomised controlled trials (RCTs) on substance use and mental health treatment (23 as lead CI including 11 NHMRC-funded RCTs). She also develops web and mobile-phone based programs (16 RCTs). Most of this research has been conducted with industry partners (e.g., Lives Lived Well, Qld Health).

Hides has been in research only positions since 2010, funded by prestigious fellowships including an NHMRC Senior Research Fellowship (2017-21), ARC Future Fellowship (2012-16) and a Vice Chancellor’s Senior Research Fellowship (Queensland University of Technology, 2010-13). Her research has been supported by $46m in grants ($37 nationally competitive) including 15 NHMRC ($14.5m; 3 as CIA including a Centre for Research Excellence), 3 MRFF ($7m) and 2 ARC ($1m) grants. Professor Hides has 248 career publications, including 243 journal articles with over 10,000 citations.

Prof Hides' current research interests include:

• Developing and testing new models for understanding youth substance use and comorbidity
• Improving the treatment of youth substance use and comorbidity by:
  • Integrating more strengths-based approaches
  • Identifying and enhancing mechanisms of change
  • Combining psychological and pharmacological treatments,
  • Integrating mobile phone and web-based interventions
• Understanding the relationship between youth wellbeing and mental disorders
• Development of mobile phone and web-based interventions targeting the mental health and wellbeing of young people
  • Ray’s night out: mobile app targeting risky alcohol use
  • music eScape: mobile app using music to improve affect regulation
  • Breakup Shakeup: mobile app for coping with relationship breakups
  • Keep it Real: web-based program targeting psychotic-like experiences in substance users
  • Routine outcome monitoring (ROM) plus feedback in SMART Recovery Australia: a feasibility study examining SMART ROM (led by A/Prof Kelly, UoW).
• Training, supervision, and dissemination of evidence-based practice

Nationally Competitive Funding

• NHMRC Centre for Research Excellence (led by Prof Hides, UQ): Meaningful Outcomes in Substance use Treatment. See https://mo-cre.centre.uq.edu.au/
• Commonwealth Department of Health (Connor & Hides), National Centre for Youth Substance Use Research (NCYSUR) National Addiction Centre
• MRFF Health and Healthy Lifestyles (led by Prof Bonevski, Flinders University): "Escape the vape" Designing health communications for prevention of e-cigarette use in young people
• MRFF Health and Healthy Lifestyles (led by Prof Newton, Matilda Centre Uni Syd): A new scalable e-health appraoch to prevent e-cigarette use amongh adolescents: The OurFutures Vaping Program
• NHMRC Ideas Grant (led by Prof Johnson): Understanding and Treating Videogame Addiction in Young People
• Alcohol and Drug Foundation Research Grant (led by Prof Kelly): Building peer and provider capacity to effectively deliver SMART Family & friends meetings: A two stage mixed- methods evaluation.
• MRFF Million Minds (led by Prof March, USQ): Translating evidence-based interventions into population-level digital models of care for child & adolescent mental health
• NHMRC Project (led by Prof Hides): Brief interventions to prevent future alcohol-related harm in young people presenting to emergency departments.
• NHMRC Project (led by Prof Hides: Randomised controlled trial of a telephone-delivered social well-being and engaged living (SWEL) intervention for disengaged at-risk youth
• NHMRC Project (led by Prof Teesson, University of Sydney)- Internet-based universal prevention for anxiety, depression and substance use in young Australians
• NHMRC Project (led by Prof Teesson, University of Sydney)- Healthy, wealthy and wise: The long-term effectiveness of an online universal program to prevent substance use and mental health problems among Australian youth
• Paul Ramsay Foundation (led by Prof Teesson, University of Sydney): The Healthy Lifestyles program: An innovative online primary and secondary prevention intervention
• NHMRC Project (led by Prof Kavanagh, QUT) - Trial of a new low-cost treatment to support self-management of Alcohol Use Disorder: Functional Imagery Training
• NHMRC Project (led by Prof Toombs, University of QLD) - Indigenous Network Suicide Intervention Skills Training (INSIST): Can a community designed and delivered framework reduce suicide/self-harm in Indigenous youth?
• NHMRC Project (led by Prof Collins, University of Newcastle) Efficacy and cost-effectiveness of varying levels of technology-delivered personalised feedback on dietary patterns in motivating young Australian adults to improve diet quality and eating habits: The Advice, Ideas and Motivation for My Eating study
• NHMRC Project (led by Prof Cotton, University of Melbourne) - Rates, patterns and predictors of long-term outcome in a treated first-episode psychosis cohort

MBChB FRCA FANZCA FFICM PhD

Professor Geoff Hill MBChB MD BHB FRCPA FRACP geoffH@qimr.edu.au

NHMRC Australia and QLD Health Senior Clinical Research Fellow

Coordinator, Cancer Programme, QIMR Berghofer

Head, Bone Marrow Transplantation Laboratory, QIMR Berghofer

Director of Research, Cancer Care Services, Royal Brisbane & Womens’ Hospital

Bone Marrow Transplant Physician and Haematologist, Royal Brisbane & Womens’ Hospital

Geoff Hill is a medical graduate of the University of Auckland and Haematologist, training in New Zealand, The Dana Farber Cancer Institute in Boston. He is a NHMRC Australia Fellow and his immunology laboratory focuses on the interactions between cytokines, antigen presenting cells and regulatory T cells during transplantation.

Professor Hill was the 2005 Queenslander of the Year and recipient of the Transplantation Society of Australia and New Zealand 2009 Ian McKenzie Award and the 2014 Translational Research Institute National Prize for excellence within basic and clinical research in the transplant field. He was also awarded a Queensland Health Senior Clinical Research Fellowship in 2010 to translate new cytokine and cell based therapies into clinic practice.

Jess has worked as a paediatric occupational therapist in private practice since graduating from her undergraduate degree. She gained additional training in animal-assisted therapy (canine and equine) in 2015 and became interested in the role animals could play in facilitating client motivation and engagement within therapy sessions. This interest led Jess to complete her PhD exploring the efficacy of canine-assisted occupational therapy with autistic children. Since completing her PhD Jess has continued her research into the impact of human-animal interaction to human and animal health and wellbeing resulting in a number of publications. In line with this research Jess is also the Co-director of The University of Queensland Animal-Assisted intervention Alliance, and the Community Engagement Manager for Animal Therapies Ltd. Jess is also qualified as a personal trainer and has clinical and research experience working to support people with disability engage in physical activity. Jess is a current researcher and coach within the UQ ParaSTART Program.

Queensland Brain Institute

Dr Massimo A. Hilliard received his PhD in Biological Chemistry and Molecular Biology in 2001 from the University of Naples, Italy. His experimental work, performed at the Institute of Genetics and Biophysics of the CNR (Italian National Council of Research), was aimed at understanding the neuronal and genetic basis of aversive taste behavior (bitter taste) in C. elegans.

During his first postdoc at the University of California, San Diego, using the Ca2+ indicator Cameleon he published the first direct visualisation of chemosensory activity in C. elegans neurons. In his second postdoctoral work at the University of California, San Francisco and at The Rockefeller University, he switched from neuronal function to neuronal development, focusing in particular on how neurons establish and orient their polarity with respect to extracellular cues.

From September 2007, he is at the Queensland Brain Institute where he established an independent laboratory.

Paul W. Hodges DSc MedDr PhD BPhty(Hons) FAA FACP APAM(Hon) is an National Health and Medical Research Council (NHMRC) Leadership Fellow (Level 3), Professor and Director of the Centre for Innovation in Pain and Health Research (CIPHeR) at The University of Queensland (UQ). He is lead chief investigator on an NHMRC Synergy Grant that includes colleagues from the Universities of Queensland, Adelaide and South Australia, and the South Australian Health and Medical Research Institute. Paul is a Fellow of the Australian Academy of Science, which is a Fellowship of the nation’s most distinguished scientists, elected by their peers for outstanding research that has pushed back the frontiers of knowledge. He is also a Fellow of the Australian College of Physiotherapists, the Australian Academy of Health and Medical Science, and was made an Honoured member of the Australian Physiotherapy Association, their highest honour.

Paul is a recognised world leader in movement control, pain and rehabilitation. His unique comprehensive research approach from molecular biology to brain physiology and human function has led to discoveries that have transformed understanding of why people move differently in pain. His innovative research has also led to discoveries of changes in neuromuscular function across a diverse range of conditions from incontinence to breathing disorders. These observations have been translated into effective treatments that have been tested and implemented internationally.

Paul has received numerous national and international research awards that span basic and clinical science. These include the premier international award for spine research (ISSLS Prize) on five occasions; three times in Basic Science (2006, 2011, 2019) and twice in Clinical Science (2018, 2021). International awards in basic science include the SusanneKlein-Vogelbach Award (2010) and the Delsys Prize for Innovation in Electromyography (2009). National medical research awards include the NHMRC Achievement Award (2011). He has also received national community-based leadership awards including the Young Australian of the Year Award in Science and Technology (1997), Future Summit Australian Leadership Award (2010), and Emerging Leader Award (Next 100 Awards, 2009).

Paul is the Chair of the Terminology Task Force for the International Association for the Study of Pain, Chair of the Consensus for Experimental Design in Electromypgraphy for the International Society for Electrophysiology and Kinesiology and has been the Chair/Co-Chair for several major international conferences. He has led major international consortia to bring together leaders from multiple disciplines to understand pain.

I am an academic and consultant working in global health with a focus on health technology assessment (HTA), health systems and services research, and the use of medicines in populations. I have a particular interest in the use of data and research for evidence-informed decision making and implementation science in the context of low and middle income countries, especially in sub-Saharan Africa. I have worked on international health projects in Indonesia and am currently working on several projects in HTA and medicines use in Ghana and sub-Saharan Africa. I work with an extensive network of clinicians and health professionals to investigate the use of medicines and adverse effects in general practice, cancer, psychiatry, neurology, and internal medicine. I have honorary or visiting appointments at the University of Queensland (UQ, Brisbane, Australia), Imperial College London (UK, International Decision Support Initiative) and Kwame Nkrumah University of Science and Technology (KNUST, Kumasi, Ghana). I have a BSc(Hons) and MPH from UQ and a PhD from Monash University. I have lived or worked in Australia (Brisbane, Melbourne), Canada (Toronto), Indonesia (Yogyakarta), UK (London), and Ghana (Accra, Kumasi). I worked as a consultant in HTA in Australia for many years evaluating submissions to subsidise medicines on the Pharmaceutical Benefits Scheme (PBS). I am an experienced teacher having coordinated courses, lectured, and tutored in undergraduate and postgraduate programs. I was a Foundation Coordinator in the UQ Master of Pharmaceutical Industry Practice (from 2019). I am an advisor on diverse PhD and student research projects.

I graduated with Honours in Medicine from the University of the West Indies, Jamaica, in 1992. In 1997 I relocated to the UK where I specialised in Obstetrics & Gynaecology and was admitted as a Member of the Royal College of Obstetricians & Gynaecologists in 1999. In 2012 I gained dual accreditation as a Subspecialist in Reproductive Medicine & Surgery and was admitted to the European Specialist Register. In 2012, I was appointed Senior Lecturer and Consultant in Reproductive Medicine & Surgery at University College London (UCL) and UCL Hospitals where I was the clinical lead for IVF and Recurrent Miscarriage and the scientific lead for Mammalian Oocyte Research within UCL’s Institute for Women’s Health. In January 2014 I relocated to Australia after being recruited to UNSW through the DVCR’s Strategic Priority Funding Scheme. At UNSW I jointly set up and co-directed UNSW’s first oocyte biology research lab. In January 2016, following a competitive global search, I was appointed to the fully endowed Christopher Chen Chair in Reproductive Medicine at UQ where I currently head the Christopher Chen Oocyte Research Laboratory. Since relocating to Australia I have been awarded Fellowship of the Royal Australian NZ College of Obstetricians & Gynaecologists.

In parallel with clinical activity, I have developed an internationally leading research program investigating oocyte maturation and oocyte quality. My Ph.D was awarded in 2009 from the University of Newcastle-upon-Tyne (UK) and received a Dean’s commendation. My thesis investigated the regulation of chromosome segregation in mouse and human oocytes and was funded by a WellBeing of Women Research Training Fellowship. My post-doctoral research was undertaken at UCL funded by a prestigious Wellcome Trust Clinician Scientist Fellowship ($1.2 million). At UCL, I was one of the principal investigators in the cross-faculty Mammalian Oocyte and Embryo Research Laboratory. In my first 2 years in Australia, I have secured NHMRC funding as CIA worth over $1 million.

I have placed leading papers on oocyte regulation in high impact journals such as Science, Developmental Cell, Genes & Development and Nature Cell Biology all of which have been cited by the Faculty of 1000 Experts. I have received numerous prizes and awards including the highly prestigious Medical Research Society Young Investigator Award (first and only award made to the specialty of O&G in the UK) and was the first of the UK Walport Clinical Lecturers in all specialties to attain Clinician Scientist status. I was one of the very few to have delivered the RCOG’s William Blair Bell Memorial Lecture whilst still a clinical trainee.

Melanie Hoyle is a Lecturer in Occupational Therapy at The University of Queensland. She completed her PhD is 2022 and Masters in Occupational Therapy Studies in 2004. These degrees were on the back of previously completed studies in science, psychology, health management and health promotion. Melanie has practiced in a broad range of clinical areas, with diverse population groups. She is passionate about partnering with people to support participation in occupations and improve life satisfaction regardless of health condition. Presently her research interests are concentrated on factors that impact on people’s participation in the community and her PhD focused on exploring these influences with people who have experience stroke. She also has research interests in the impact of the NDIS on consumer and clincians experiences in service provision, assistive technology and home-modifications and their influence on participation outcomes, and facilitating leisure opportunities for people with disabilities.

Ruth E. Hubbard is a Consultant Geriatrician at the Princess Alexandra Hospital and in October 2020 was appointed as the Masonic Chair of Geriatric Medicine at the University of Queensland.

She qualified from St Mary’s Hospital Medical School in London and trained in general internal medicine and geriatric medicine in Cardiff, Wales. As a clinical academic, she has always combined hospital practice with research and teaching. She has completed an MSc in Medical Education, an MD on pathophysiological changes in frail older people and a post-doctoral fellowship in Dalhousie University, Nova Scotia with Professor Ken Rockwood. Here, she was able to test hypotheses regarding the determinants and manifestations of frailty through the interrogation of large datasets. She has published widely on the inflammatory aetiology of frailty, the difficulties of measuring frailty in clinical practice and the relationships between frailty and obesity, smoking, socioeconomic status and exercise. Based on the impact of her publications, she is currently ranked number 4 in a list of frailty experts worldwide (http://expertscape.com/ex/frail+elderly).

In the last 5 years, she has generated $24.5M in grant income including as CIA on the following: MRFF Dementia Ageing and Aged Care Mission ($5M), a Centre for Research Excellence in Frailty ($2.5M), an Ideas Grant ($1.6M) and the NHMRC Targeted Call for Frailty Research ($1.5M). As Founder and Director of the Australia Frailty Network (AFN), she has established a team of consumer partners, multidisciplinary clinical academics, behavioural psychologists and statisticians answering critical questions relating to the measurement and management of frailty.

The research interests of the Hume Laboratory centre on the biology of macrophages and osteoclasts. These are cells of haematopoietic origin that are closely related to each other but have distinctly different activities.

David Hume was a group leader at the Institute for Molecular Bioscience (1988-2007) and subsequently Director of the Roslin Institute at the University of Edinburgh in Scotland from 2007-2017. He is currently a Professorial Research Fellow at the Mater Research Institute-UQ, located at the Translational Research Institute